Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Directorate Change

22 Sep 2016 07:00

RNS Number : 5018K
Centaur Media PLC
22 September 2016
 

 22 September 2016

Centaur Media Plc

("Centaur Media"or "the Company")

Appointment of Chief Financial Officer

Centaur Media plc (LSE: CAU), the multi-platform business information, insight and events group, has appointed Swag Mukerji Chief Financial Officer. Swag has been Interim Chief Financial Officer since 29 July 2016.

Swag has had senior finance and general management positions with several blue chip FMCG companies and was formerly Group Finance Director of Biocompatibles International plc. Since then he has been CFO of three private equity backed businesses, the latest of which was Safetykleen, a Warburg Pincus Investment.

Andria Vidler, CEO of Centaur commented:

"Swag has exceptional commercial and operational experience in a range of sectors, I am therefore delighted to confirm that Swag will be appointed as Chief Financial Officer and will join the board of the Company with effect from 1st October 2016."

The Company confirms that there is no further information about Swag Mukerji requiring disclosure under paragraph 9.6.13 (2) to (6) of the Listing Rules of the UK Listing Authority.

 

For further enquiries:

Centaur Media plc

Grainne Brankin, Company Secretary 020 7970 4000

 

IR Focus

Neville Harris 07909 976044

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADFLFLQKFZBBQ
Date   Source Headline
21st Apr 20268:00 amRNSCancellation - Centaur Media PLC
20th Apr 20265:52 pmRNSHolding(s) in Company
16th Apr 20269:41 amRNSHolding(s) in Company
16th Apr 20269:39 amRNSHolding(s) in Company
16th Apr 20269:37 amRNSHolding(s) in Company
16th Apr 20269:36 amRNSHolding(s) in Company
7th Apr 20265:45 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:52 pmRNSHolding(s) in Company
1st Apr 20264:41 pmRNSHolding(s) in Company
31st Mar 20264:23 pmRNSHolding(s) in Company
31st Mar 202611:15 amRNSHolding(s) in Company
30th Mar 20264:44 pmRNSHolding(s) in Company
30th Mar 202611:19 amRNSHolding(s) in Company
30th Mar 202611:06 amRNSHolding(s) in Company
27th Mar 20262:30 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSResult of Tender Offer
23rd Mar 202612:08 pmRNSUpdate on Tender Offer
17th Mar 20261:25 pmRNSResult of Court Hearing
26th Feb 20267:00 amRNSResult of General Meeting
18th Feb 20267:00 amRNSStrategic Partnership
10th Feb 20262:44 pmRNSHolding(s) in Company
5th Feb 20263:59 pmRNSHolding(s) in Company
4th Feb 202611:24 amRNSHolding(s) in Company
30th Jan 20267:00 amRNSTender Offer
6th Jan 20267:00 amRNSTender offer update and sale of Econsultancy
24th Nov 202510:57 amRNSChange of Registered Office
29th Oct 20258:28 amRNSUpdate on Return of Capital
22nd Oct 20254:14 pmRNSHolding(s) in Company
22nd Oct 202512:03 pmRNSHolding(s) in Company
21st Oct 20254:39 pmRNSHolding(s) in Company
21st Oct 20252:12 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSDirector/PDMR Shareholding
9th Oct 20255:15 pmRNSDirector/PDMR Shareholding
8th Oct 20252:00 pmRNSSale of The Lawyer
25th Sep 20257:00 amRNSAgreement for the sale of Marketing Week
17th Sep 20257:00 amRNSInterim results for the 6 months ended 30 Jun 2025
11th Sep 20257:00 amRNSConditional agreement for the sale of The Lawyer
5th Sep 20252:00 pmRNSHolding(s) in Company
27th Aug 202512:30 pmRNSHolding(s) in Company
19th Aug 20259:39 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
25th Jun 20257:00 amRNSConditional agreement for the sale of MiniMBA
19th Jun 20257:00 amRNSExtension to Exclusivity
22nd May 202512:00 pmRNSDirector/PDMR Shareholding
9th May 20258:16 amRNSResponse to Media Speculation
8th May 202512:33 pmRNSResult of AGM
22nd Apr 202512:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.